Document Detail


Diuresis and pulmonary function in premature infants with respiratory distress syndrome.
MedLine Citation:
PMID:  6352887     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A prospective study of 99 premature infants with severe respiratory distress syndrome who were randomly assigned to receive diuretic treatment with either furosemide or chlorothiazide was analyzed to examine the relationship of diuretic administration and diuresis to survival and to the duration and degree of mechanical ventilatory support. Subjects were given a diuretic, usually beginning on the second or third day of life, if they had not initiated the expected spontaneous diuresis and did not show pulmonary improvement. Infants given furosemide experienced a postnatal weight loss nearly identical to that in infants who were deemed not to need a diuretic; infants given chlorothiazide lost weight more slowly and had significantly greater body weight on postnatal days 4 and 5. Four factors were independently correlated with improved survival: furosemide usage, high birth weight, low initial mean airway pressure, and the absence of intraventricular hemorrhage. Ventilator mean airway pressure on the seventh day of life and duration of mechanical ventilation were both related to diuresis. These data provide additional evidence for the importance of water homeostasis in determining the course of respiratory distress syndrome in premature infants and indicate that furosemide administration is beneficial when spontaneous diuresis does not occur. Furosemide may be particularly effective if combined with early closure of the ductus arteriosus.
Authors:
T P Green; T R Thompson; D E Johnson; J E Lock
Related Documents :
9560047 - Tension pneumopericardium in a preterm infant without mechanical ventilation: a rare ca...
23922667 - Dna methyltransferase candidate polymorphisms, imprinting methylation, and birth outcome.
24041147 - Prevalence of anemia in pregnant women and its effect on neonatal outcomes in northeast...
6168997 - Early development of infants of birth weight less than 1,000 grams with reference to me...
20016397 - Population based external validation of a european predictive model for respiratory syn...
20576727 - Specific requirements for bloodless cardiopulmonary bypass in neonates and infants; a r...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of pediatrics     Volume:  103     ISSN:  0022-3476     ISO Abbreviation:  J. Pediatr.     Publication Date:  1983 Oct 
Date Detail:
Created Date:  1983-11-23     Completed Date:  1983-11-23     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0375410     Medline TA:  J Pediatr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  618-23     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chlorothiazide / therapeutic use
Clinical Trials as Topic
Diuresis* / drug effects*
Ductus Arteriosus, Patent / drug therapy,  mortality,  physiopathology
Furosemide / therapeutic use
Humans
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases / drug therapy,  mortality,  physiopathology*
Lung / physiopathology*
Prospective Studies
Respiration, Artificial
Respiratory Distress Syndrome, Newborn / drug therapy,  mortality,  physiopathology*
Chemical
Reg. No./Substance:
54-31-9/Furosemide; 58-94-6/Chlorothiazide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relation of enteroinsular hormones at birth to macrosomia and neonatal hypoglycemia in infants of di...
Next Document:  Plasmid-mediated adhesion in enteropathogenic Escherichia coli.